Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (17)

« Back to Publications

Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM Registry.

Beyhoff N. et al, (2026), JACC Cardiovasc Imaging, 19, 133 - 135

Comparison of cardiac diffusion MRI using multiple prospective respiratory motion correction techniques.

Jermy S. et al, (2026), Magn Reson Med, 95, 442 - 456

Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.

Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26

Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.

Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228

1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID

Finnigan LEM. et al, (2024), Radiology, 313

Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study.

Samat AHA. et al, (2024), Int J Cardiol, 415

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.

Coleman JA. et al, (2024), Cardiovasc Res, 120, 914 - 926

Flow inefficiencies in non-obstructive HCM revealed by kinetic energy and hemodynamic forces on 4D-flow CMR.

Pola K. et al, (2024), Eur Heart J Imaging Methods Pract, 2

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.

Coleman JA. et al, (2023), Int J Cardiovasc Imaging, 39, 1979 - 1996

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.

Ashkir Z. et al, (2023), Eur Heart J Cardiovasc Imaging, 24, 1192 - 1200

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.

Farrant J. et al, (2023), Heart, 109, 1175 - 1182

Intracardiac incidentaloma in a young woman.

Ashkir Z. et al, (2022), Heart, 108, 592 - 660

Four-dimensional flow cardiac magnetic resonance assessment of left ventricular diastolic function.

Ashkir Z. et al, (2022), Front Cardiovasc Med, 9

NOVEL INSIGHTS INTO DIMINISHED CARDIAC RESERVE IN HYPERTROPHIC CARDIOMYOPATHY FROM 4D FLOW CMR COMPONENT ANALYSIS

Ashkir Z. et al, (2022), HEART, 108, A3 - A4

Pleural empyema: a case of failing to see the discharge leading to discharge failure.

Ashkir Z. et al, (2017), Postgrad Med J, 93

Load More